Officials from the American pharmaceutical company 'VaxGen' state that an HIV vaccine may be available by 2005. At the largest AIDS conference held in Barcelona, Spain, company officials from California said that if the safety and efficacy trial results for humans meet scientists' expectations, the drug will be available to the global population in three years to protect themselves against HIV. The officials from 'VaxGen' claim that the drug has been effective in monkeys and are optimistic that it will be equally beneficial for humans. Results from human trials will be known next year. Officials say that this vaccine does not prevent infection by the HIV virus but creates antibodies in the body that prevent the virus from attaching to body cells, thereby preventing severe HIV infection.
HIV Vaccine May Be Available by 2005
The American pharmaceutical company VaxGen announced that an HIV vaccine could be available by 2005 if human trials yield positive results. This development is significant as it offers hope for a preventive measure against HIV/AIDS. The vaccine is designed to create antibodies rather than prevent infection outright.
👥 Key Players
📰 What Happened
VaxGen announced that an HIV vaccine may be available by 2005 if human trials show positive results. The vaccine aims to create antibodies that prevent severe HIV infection.
- The vaccine has shown effectiveness in monkeys.
- Human trial results are expected next year.
💡 Why It Matters
📚 Background
HIV/AIDS remains a global health crisis, with millions affected worldwide. Vaccines are crucial for prevention and control of the virus.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%